Mutation allele burden remains unchanged in chronic myelomonocytic leukaemia responding to hypomethylating agents

Merlevede, Jane; Droin, Nathalie; Qin, Tingting; Meldi, Kristen; Yoshida, Kenichi; Morabito, Margot; Chautard, Emilie; Auboeuf, Didier; Fenaux, Pierre; Braun, Thorsten; Itzykson, Raphael; de Botton, Stephane; Quesnel, Bruno; Commes, Therese; Jourdan, Eric; Vainchenker, William; Bernard, Olivier; Pata-Merci, Noemie; Solier, Stephanie; Gayevskiy, Velimir; Dinger, Marcel E.; Cowley, Mark J.; Selimoglu-Buet, Dorothee; Meyer, Vincent; Artiguenave, Francois; Deleuze, Jean -Francois; Preudhomme, Claude; Stratton, Michael R.; Alexandrov, Ludmil B.; Padron, Eric; Ogawa, Seishi; Koscielny, Serge; Figueroa, Maria; Solary, Eric

doi:10.1038/ncomms10767

Title: Mutation allele burden remains unchanged in chronic myelomonocytic leukaemia responding to hypomethylating agents

Journal Article · Wed Feb 24 00:00:00 EST 2016 · Nature Communications

DOI:https://doi.org/10.1038/ncomms10767· OSTI ID:1246362

Merlevede, Jane ^[1]; Droin, Nathalie ^[2]; Qin, Tingting ^[3]; Meldi, Kristen ^[3]; Yoshida, Kenichi ^[4]; Morabito, Margot ^[1];

^[5]; Auboeuf, Didier ^[6]; Fenaux, Pierre ^[7]; Braun, Thorsten ^[8]; Itzykson, Raphael ^[7]; de Botton, Stephane ^[1]; Quesnel, Bruno ^[9]; Commes, Therese ^[10]; Jourdan, Eric ^[11]; Vainchenker, William ^[1]; Bernard, Olivier ^[1]; Pata-Merci, Noemie ^[12]; Solier, Stephanie ^[1]; Gayevskiy, Velimir ^[13] more »

INSERM U1170, Villejuif (France); Gustave Roussy Cancer Center, Villejuif (France)
INSERM U1170, Villejuif (France); Gustave Roussy Cancer Center, Villejuif (France); INSERM US23, Villejuif (France)
Univ. of Michigan Medical School, Ann Arbor, MI (United States)
Kyoto Univ., Kyoto (Japan)
Univ. Lyon 1, UMR CNRS 5558, Univ. Claude Bernard, Lyon (France)
Centre Leon Berard, INSERM U1052, CNRS UMR5286, Lyon (France)
Hopital Saint-Louis, Paris (France)
Hopital Avicenne, Bobigny (France)
Cancer Research Institute de Lille, INSERM U837, Lille (France)
INSERM U1040, Univ. de Montpellier, Montpellier (France)
Centre Hospitalier Univ. de Nimes, Univ. Montpellier-Nimes, Nimes (France)
INSERM US23, Villejuif (France)
Kinghor Center for Clinical Genomics, Garvan Institute of Medical Research, Darlinghurst New South Wales (Australia)
Centre National de Genotypage, Evry (France)
Wellcome Trust Sanger Institute, Cambridgeshire (United Kingdom)
Los Alamos National Lab. (LANL), Los Alamos, NM (United States); Wellcome Trust Sanger Institute, Cambridgeshire (United Kingdom)
H. Lee Moffitt Cancer Center, Tampa, FL (United States)
Gustave Roussy Cancer Center, Villejuif (France)
INSERM U1170, Villejuif (France); Gustave Roussy Cancer Center, Villejuif (France); Univ. Paris-Sud, Le Kremlin-Bicetre (France)

The cytidine analogues azacytidine and 5-aza-2’-deoxycytidine (decitabine) are commonly used to treat myelodysplastic syndromes, with or without a myeloproliferative component. It remains unclear whether the response to these hypomethylating agents results from a cytotoxic or an epigenetic effect. In this study, we address this question in chronic myelomonocytic leukaemia. We describe a comprehensive analysis of the mutational landscape of these tumours, combining whole-exome and whole-genome sequencing. We identify an average of 14 ± 5 somatic mutations in coding sequences of sorted monocyte DNA and the signatures of three mutational processes. Serial sequencing demonstrates that the response to hypomethylating agents is associated with changes in DNA methylation and gene expression, without any decrease in the mutation allele burden, nor prevention of new genetic alteration occurence. Lastly, our findings indicate that cytosine analogues restore a balanced haematopoiesis without decreasing the size of the mutated clone, arguing for a predominantly epigenetic effect.

View Accepted Manuscript (DOE)

Cite

Export

Save

Research Organization:: Los Alamos National Laboratory (LANL), Los Alamos, NM (United States)

Sponsoring Organization:: USDOE

Grant/Contract Number:: AC52-06NA25396

OSTI ID:: 1246362

Report Number(s):: LA-UR-15-24070; ncomms10767

Journal Information:: Nature Communications, Vol. 7; ISSN 2041-1723

Publisher:: Nature Publishing GroupCopyright Statement

Country of Publication:: United States

Language:: English

Citation Metrics:

Cited by: 148 works

Citation information provided by
Web of Science

References (89)

The 2008 revision of the World Health Organization (WHO) classification of myeloid neoplasms and acute leukemia: rationale and important changes Vardiman, James W.; Thiele, Jüergen; Arber, Daniel A. Blood, Vol. 114, Issue 5 https://doi.org/10.1182/blood-2009-03-209262	journal	July 2009
Mutational spectrum analysis of chronic myelomonocytic leukemia includes genes associated with epigenetic regulation: UTX, EZH2, and DNMT3A Jankowska, Anna M.; Makishima, Hideki; Tiu, Ramon V. Blood, Vol. 118, Issue 14 https://doi.org/10.1182/blood-2010-10-311019	journal	October 2011
Clonal architecture of chronic myelomonocytic leukemias Itzykson, Raphaël; Kosmider, Olivier; Renneville, Aline Blood, Vol. 121, Issue 12 https://doi.org/10.1182/blood-2012-06-440347	journal	March 2013
Recurrent mutations in multiple components of the cohesin complex in myeloid neoplasms Kon, Ayana; Shih, Lee-Yung; Minamino, Masashi Nature Genetics, Vol. 45, Issue 10 https://doi.org/10.1038/ng.2731	journal	August 2013
Frequent pathway mutations of splicing machinery in myelodysplasia Yoshida, Kenichi; Sanada, Masashi; Shiraishi, Yuichi Nature, Vol. 478, Issue 7367 https://doi.org/10.1038/nature10496	journal	September 2011
Genome profiling of chronic myelomonocytic leukemia: frequent alterations of RAS and RUNX1genes Gelsi-Boyer, Véronique; Trouplin, Virginie; Adélaïde, José BMC Cancer, Vol. 8, Issue 1 https://doi.org/10.1186/1471-2407-8-299	journal	October 2008
Mutation of the colony-stimulating factor-3 receptor gene is a rare event with poor prognosis in chronic myelomonocytic leukemia Kosmider, O.; Itzykson, R.; Chesnais, V. Leukemia, Vol. 27, Issue 9 https://doi.org/10.1038/leu.2013.182	journal	June 2013
Novel recurrent mutations in the RAS-like GTP-binding gene RIT1 in myeloid malignancies Gómez-Seguí, I.; Makishima, H.; Jerez, A. Leukemia, Vol. 27, Issue 9 https://doi.org/10.1038/leu.2013.179	journal	June 2013
A novel tumour-suppressor function for the Notch pathway in myeloid leukaemia Klinakis, Apostolos; Lobry, Camille; Abdel-Wahab, Omar Nature, Vol. 473, Issue 7346 https://doi.org/10.1038/nature09999	journal	May 2011
Putative RNA-splicing gene LUC7L2 on 7q34 represents a candidate gene in pathogenesis of myeloid malignancies Singh, H.; Lane, A. A.; Correll, M. Blood Cancer Journal, Vol. 3, Issue 5 https://doi.org/10.1038/bcj.2013.16	journal	May 2013
Recurrent ETNK1 mutations in atypical chronic myeloid leukemia Gambacorti-Passerini, Carlo B.; Donadoni, Carla; Parmiani, Andrea Blood, Vol. 125, Issue 3 https://doi.org/10.1182/blood-2014-06-579466	journal	January 2015
Prognostic Score Including Gene Mutations in Chronic Myelomonocytic Leukemia Itzykson, Raphaël; Kosmider, Olivier; Renneville, Aline Journal of Clinical Oncology, Vol. 31, Issue 19 https://doi.org/10.1200/JCO.2012.47.3314	journal	July 2013
ASXL1 and SETBP1 mutations and their prognostic contribution in chronic myelomonocytic leukemia: a two-center study of 466 patients Patnaik, M. M.; Itzykson, R.; Lasho, T. L. Leukemia, Vol. 28, Issue 11 https://doi.org/10.1038/leu.2014.125	journal	April 2014
Transient Low Doses of DNA-Demethylating Agents Exert Durable Antitumor Effects on Hematological and Epithelial Tumor Cells Tsai, Hsing-Chen; Li, Huili; Van Neste, Leander Cancer Cell, Vol. 21, Issue 3 https://doi.org/10.1016/j.ccr.2011.12.029	journal	March 2012
Molecular predictors of response to decitabine in advanced chronic myelomonocytic leukemia: a phase 2 trial Braun, Thorsten; Itzykson, Raphael; Renneville, Aline Blood, Vol. 118, Issue 14 https://doi.org/10.1182/blood-2011-05-352039	journal	October 2011
Characteristic repartition of monocyte subsets as a diagnostic signature of chronic myelomonocytic leukemia Selimoglu-Buet, Dorothée; Wagner-Ballon, Orianne; Saada, Véronique Blood, Vol. 125, Issue 23 https://doi.org/10.1182/blood-2015-01-620781	journal	June 2015
Titin mutations in iPS cells define sarcomere insufficiency as a cause of dilated cardiomyopathy Hinson, J. T.; Chopra, A.; Nafissi, N. Science, Vol. 349, Issue 6251 https://doi.org/10.1126/science.aaa5458	journal	August 2015
Exome sequencing identifies recurrent mutations of the splicing factor SF3B1 gene in chronic lymphocytic leukemia Quesada, Víctor; Conde, Laura; Villamor, Neus Nature Genetics, Vol. 44, Issue 1 https://doi.org/10.1038/ng.1032	journal	December 2011
Recurrent mutations in epigenetic regulators, RHOA and FYN kinase in peripheral T cell lymphomas Palomero, Teresa; Couronné, Lucile; Khiabanian, Hossein Nature Genetics, Vol. 46, Issue 2 https://doi.org/10.1038/ng.2873	journal	January 2014
Genetic characterization of TET1, TET2, and TET3 alterations in myeloid malignancies Abdel-Wahab, Omar; Mullally, Ann; Hedvat, Cyrus Blood, Vol. 114, Issue 1 https://doi.org/10.1182/blood-2009-03-210039	journal	July 2009
TET proteins and 5-methylcytosine oxidation in hematological cancers Ko, Myunggon; An, Jungeun; Pastor, William A. Immunological Reviews, Vol. 263, Issue 1 https://doi.org/10.1111/imr.12239	journal	December 2014
Deciphering Signatures of Mutational Processes Operative in Human Cancer Alexandrov, Ludmil B.; Nik-Zainal, Serena; Wedge, David C. Cell Reports, Vol. 3, Issue 1 https://doi.org/10.1016/j.celrep.2012.12.008	journal	January 2013
Signatures of mutational processes in human cancer Alexandrov, Ludmil B.; Nik-Zainal, Serena; Wedge, David C. Nature, Vol. 500, Issue 7463 https://doi.org/10.1038/nature12477	journal	August 2013
TERT Promoter Mutations in Familial and Sporadic Melanoma Horn, S.; Figl, A.; Rachakonda, P. S. Science, Vol. 339, Issue 6122 https://doi.org/10.1126/science.1230062	journal	January 2013
Exome sequencing of hepatocellular carcinomas identifies new mutational signatures and potential therapeutic targets Schulze, Kornelius; Imbeaud, Sandrine; Letouzé, Eric Nature Genetics, Vol. 47, Issue 5 https://doi.org/10.1038/ng.3252	journal	March 2015
Recurrent somatic mutations in regulatory regions of human cancer genomes Melton, Collin; Reuter, Jason A.; Spacek, Damek V. Nature Genetics, Vol. 47, Issue 7 https://doi.org/10.1038/ng.3332	journal	June 2015
An atlas of active enhancers across human cell types and tissues Andersson, Robin; Gebhard, Claudia; Miguel-Escalada, Irene Nature, Vol. 507, Issue 7493 https://doi.org/10.1038/nature12787	journal	March 2014
Clinical application and proposal for modification of the International Working Group (IWG) response criteria in myelodysplasia Cheson, B. D. Blood, Vol. 108, Issue 2 https://doi.org/10.1182/blood-2005-10-4149	journal	July 2006
High concordance of genomic and cytogenetic aberrations between peripheral blood and bone marrow in myelodysplastic syndrome (MDS) Mohamedali, A. M.; Gäken, J.; Ahmed, M. Leukemia, Vol. 29, Issue 9 https://doi.org/10.1038/leu.2015.110	journal	May 2015
Age-Related Clonal Hematopoiesis Associated with Adverse Outcomes Jaiswal, Siddhartha; Fontanillas, Pierre; Flannick, Jason New England Journal of Medicine, Vol. 371, Issue 26 https://doi.org/10.1056/NEJMoa1408617	journal	December 2014
Clonal Hematopoiesis and Blood-Cancer Risk Inferred from Blood DNA Sequence Genovese, Giulio; Kähler, Anna K.; Handsaker, Robert E. New England Journal of Medicine, Vol. 371, Issue 26 https://doi.org/10.1056/NEJMoa1409405	journal	December 2014
Age-related mutations associated with clonal hematopoietic expansion and malignancies Xie, Mingchao; Lu, Charles; Wang, Jiayin Nature Medicine, Vol. 20, Issue 12 https://doi.org/10.1038/nm.3733	journal	October 2014
Identification of pre-leukaemic haematopoietic stem cells in acute leukaemia Shlush, Liran I.; Zandi, Sasan; Mitchell, Amanda Nature, Vol. 506, Issue 7488 https://doi.org/10.1038/nature13038	journal	February 2014
Persistence of leukaemic ancestors Potter, Nicola E.; Greaves, Mel Nature, Vol. 506, Issue 7488 https://doi.org/10.1038/nature13056	journal	February 2014
TET2 Inactivation Results in Pleiotropic Hematopoietic Abnormalities in Mouse and Is a Recurrent Event during Human Lymphomagenesis Quivoron, Cyril; Couronné, Lucile; Della Valle, Véronique Cancer Cell, Vol. 20, Issue 1 https://doi.org/10.1016/j.ccr.2011.06.003	journal	July 2011
An evolutionary perspective on chronic myelomonocytic leukemia Itzykson, R.; Solary, E. Leukemia, Vol. 27, Issue 7 https://doi.org/10.1038/leu.2013.100	journal	April 2013
Exome sequencing identifies secondary mutations of SETBP1 and JAK3 in juvenile myelomonocytic leukemia Sakaguchi, Hirotoshi; Okuno, Yusuke; Muramatsu, Hideki Nature Genetics, Vol. 45, Issue 8 https://doi.org/10.1038/ng.2698	journal	July 2013
Azacitidine fails to eradicate leukemic stem/progenitor cell populations in patients with acute myeloid leukemia and myelodysplasia Craddock, C.; Quek, L.; Goardon, N. Leukemia, Vol. 27, Issue 5 https://doi.org/10.1038/leu.2012.312	journal	November 2012
Flow cytometry immunophenotypic findings in chronic myelomonocytic leukemia and its utility in monitoring treatment response Shen, Qi; Ouyang, Juan; Tang, Guilin European Journal of Haematology, Vol. 95, Issue 2 https://doi.org/10.1111/ejh.12477	journal	April 2015
MDS and secondary AML display unique patterns and abundance of aberrant DNA methylation Figueroa, Maria E.; Skrabanek, Lucy; Li, Yushan Blood, Vol. 114, Issue 16 https://doi.org/10.1182/blood-2009-01-200519	journal	October 2009
Specific molecular signatures predict decitabine response in chronic myelomonocytic leukemia Meldi, Kristen; Qin, Tingting; Buchi, Francesca Journal of Clinical Investigation, Vol. 125, Issue 5 https://doi.org/10.1172/JCI78752	journal	March 2015
Induction of a CD8+ T-cell response to the MAGE cancer testis antigen by combined treatment with azacitidine and sodium valproate in patients with acute myeloid leukemia and myelodysplasia Goodyear, Oliver; Agathanggelou, Angelo; Novitzky-Basso, Igor Blood, Vol. 116, Issue 11 https://doi.org/10.1182/blood-2009-11-249474	journal	September 2010
Expression of PD-L1, PD-L2, PD-1 and CTLA4 in myelodysplastic syndromes is enhanced by treatment with hypomethylating agents Yang, H.; Bueso-Ramos, C.; DiNardo, C. Leukemia, Vol. 28, Issue 6 https://doi.org/10.1038/leu.2013.355	journal	November 2013
DNA-Demethylating Agents Target Colorectal Cancer Cells by Inducing Viral Mimicry by Endogenous Transcripts Roulois, David; Loo Yau, Helen; Singhania, Rajat Cell, Vol. 162, Issue 5 https://doi.org/10.1016/j.cell.2015.07.056	journal	August 2015
Inhibiting DNA Methylation Causes an Interferon Response in Cancer via dsRNA Including Endogenous Retroviruses Chiappinelli, Katherine B.; Strissel, Pamela L.; Desrichard, Alexis Cell, Vol. 162, Issue 5 https://doi.org/10.1016/j.cell.2015.07.011	journal	August 2015
DNA Methylation Inhibitors in Cancer Therapy: The Immunity Dimension Licht, Jonathan D. Cell, Vol. 162, Issue 5 https://doi.org/10.1016/j.cell.2015.08.005	journal	August 2015
Targeting the epigenetic machinery of cancer cells Montenegro, M. F.; Sánchez-del-Campo, L.; Fernández-Pérez, M. P. Oncogene, Vol. 34, Issue 2 https://doi.org/10.1038/onc.2013.605	journal	January 2014
Cancer epigenetics drug discovery and development: the challenge of hitting the mark Campbell, Robert M.; Tummino, Peter J. Journal of Clinical Investigation, Vol. 124, Issue 1 https://doi.org/10.1172/JCI71605	journal	January 2014
The landscape of somatic mutations in Down syndrome–related myeloid disorders Yoshida, Kenichi; Toki, Tsutomu; Okuno, Yusuke Nature Genetics, Vol. 45, Issue 11 https://doi.org/10.1038/ng.2759	journal	September 2013
VarScan 2: Somatic mutation and copy number alteration discovery in cancer by exome sequencing Koboldt, D. C.; Zhang, Q.; Larson, D. E. Genome Research, Vol. 22, Issue 3 https://doi.org/10.1101/gr.129684.111	journal	February 2012
Trimmomatic: a flexible trimmer for Illumina sequence data Bolger, Anthony M.; Lohse, Marc; Usadel, Bjoern Bioinformatics, Vol. 30, Issue 15 https://doi.org/10.1093/bioinformatics/btu170	journal	April 2014
DrGaP: A Powerful Tool for Identifying Driver Genes and Pathways in Cancer Sequencing Studies Hua, Xing; Xu, Haiming; Yang, Yaning The American Journal of Human Genetics, Vol. 93, Issue 3 https://doi.org/10.1016/j.ajhg.2013.07.003	journal	September 2013
SomaticSniper: identification of somatic point mutations in whole genome sequencing data Larson, David E.; Harris, Christopher C.; Chen, Ken Bioinformatics, Vol. 28, Issue 3 https://doi.org/10.1093/bioinformatics/btr665	journal	December 2011
Strelka: accurate somatic small-variant calling from sequenced tumor–normal sample pairs Saunders, Christopher T.; Wong, Wendy S. W.; Swamy, Sajani Bioinformatics, Vol. 28, Issue 14 https://doi.org/10.1093/bioinformatics/bts271	journal	May 2012
Detecting false-positive signals in exome sequencing Fuentes Fajardo, Karin V.; Adams, David; Mason, Christopher E. Human Mutation, Vol. 33, Issue 4 https://doi.org/10.1002/humu.22033	journal	March 2012
TopHat2: accurate alignment of transcriptomes in the presence of insertions, deletions and gene fusions Kim, Daehwan; Pertea, Geo; Trapnell, Cole Genome Biology, Vol. 14, Issue 4 https://doi.org/10.1186/gb-2013-14-4-r36	journal	January 2013
Fast gapped-read alignment with Bowtie 2 Langmead, Ben; Salzberg, Steven L. Nature Methods, Vol. 9, Issue 4 https://doi.org/10.1038/nmeth.1923	journal	March 2012
HTSeq--a Python framework to work with high-throughput sequencing data Anders, S.; Pyl, P. T.; Huber, W. Bioinformatics, Vol. 31, Issue 2 https://doi.org/10.1093/bioinformatics/btu638	journal	September 2014
Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2 Love, Michael I.; Huber, Wolfgang; Anders, Simon Genome Biology, Vol. 15, Issue 12 https://doi.org/10.1186/s13059-014-0550-8	journal	December 2014
MethylSig: a whole genome DNA methylation analysis pipeline Park, Yongseok; Figueroa, Maria E.; Rozek, Laura S. Bioinformatics, Vol. 30, Issue 17 https://doi.org/10.1093/bioinformatics/btu339	journal	May 2014
Bismark: a flexible aligner and methylation caller for Bisulfite-Seq applications Krueger, Felix; Andrews, Simon R. Bioinformatics, Vol. 27, Issue 11 https://doi.org/10.1093/bioinformatics/btr167	journal	April 2011
Inhibiting DNA Methylation Causes an Interferon Response in Cancer via dsRNA Including Endogenous Retroviruses Chiappinelli, Katherine B.; Strissel, Pamela L.; Desrichard, Alexis Cell, Vol. 164, Issue 5 https://doi.org/10.1016/j.cell.2015.10.020	journal	February 2016
Persistence of adoptively transferred T cells with a kinetically engineered IL-2 receptor agonist Parisi, Giulia; Saco, Justin D.; Salazar, Felix B. Nature Communications, Vol. 11, Issue 1 https://doi.org/10.1038/s41467-019-12901-3	journal	January 2020
Cancer epigenetics drug discovery and development: the challenge of hitting the mark Campbell, Robert M.; Tummino, Peter J. Journal of Clinical Investigation, Vol. 124, Issue 3 https://doi.org/10.1172/jci75448	journal	March 2014
Datura genome reveals duplications of psychoactive alkaloid biosynthetic genes and high mutation rate following tissue culture Rajewski, Alex; Carter-House, Derreck; Stajich, Jason BMC Genomics, Vol. 22, Issue 1 https://doi.org/10.1186/s12864-021-07489-2	journal	March 2021
Characterization and functional analysis of phytoene synthase gene family in tobacco Wang, Zhaojun; Zhang, Lin; Dong, Chen BMC Plant Biology, Vol. 21, Issue 1 https://doi.org/10.1186/s12870-020-02816-3	journal	January 2021
An atlas of active enhancers across human cell types and tissues Mette, Boyd,; Berit, Lilje,; Dagmar, Glatz, The University of North Carolina at Chapel Hill University Libraries https://doi.org/10.17615/x8js-y766	text	January 2014
Deciphering signatures of mutational processes operative in human cancer. Alexandrov, Ludmil B.; Nik-Zainal Abidin, Serena; Wedge, David C. Apollo - University of Cambridge Repository https://doi.org/10.17863/cam.60112	text	January 2013
TET2 Inactivation Results in Pleiotropic Hematopoietic Abnormalities in Mouse and Is a Recurrent Event during Human Lymphomagenesis Quivoron, Cyril; Couronné, Lucile; Della Valle, Véronique Cancer Cell, Vol. 20, Issue 2 https://doi.org/10.1016/j.ccr.2011.08.006	journal	August 2011
Frequent Pathway Mutations of Splicing Machinery in Myelodysplasia Yoshida, Kenichi; Sanada, Masashi; Shiraishi, Yuichi Blood, Vol. 118, Issue 21 https://doi.org/10.1182/blood.v118.21.458.458	journal	November 2011
Novel Recurrent Mutations in the Ras-Like GTP-Binding Gene Rit1 in Myeloid Malignancies Góomez-Seguíi, Inées; Makishima, Hideki; Jerez, Andres Blood, Vol. 120, Issue 21 https://doi.org/10.1182/blood.v120.21.558.558	journal	November 2012
Clonal Hematopoiesis and Blood-Cancer Risk Inferred from Blood DNA Sequence Mikael, Landén,; E., Handsaker, Robert; Martin, Höglund, The University of North Carolina at Chapel Hill University Libraries https://doi.org/10.17615/rprj-jx97	text	January 2014
Signatures of mutational processes in human cancer. Alexandrov, Ludmil B.; Nik-Zainal Abidin, Serena; Wedge, David C. Apollo - University of Cambridge Repository https://doi.org/10.17863/cam.31889	text	January 2013
TopHat2: accurate alignment of transcriptomes in the presence of insertions, deletions and gene fusions Kim, Daehwan; Pertea, Geo; Trapnell, Cole Springer Nature https://doi.org/10.13016/7jyb-2sdy	text	January 2013
The Role of TET2 in Hematologic Neoplasms Holmfeldt, Linda; Mullighan, Charles G. Cancer Cell, Vol. 20, Issue 1 https://doi.org/10.1016/j.ccr.2011.06.025	journal	July 2011
Taking HSCs Down a Notch in Leukemia Walkley, Carl R.; Izon, David J.; Purton, Louise E. Cell Stem Cell, Vol. 8, Issue 6 https://doi.org/10.1016/j.stem.2011.04.010	journal	June 2011
In Epigenetic Therapy, Less Is More Shen, Hui; Laird, Peter W. Cell Stem Cell, Vol. 10, Issue 4 https://doi.org/10.1016/j.stem.2012.03.012	journal	April 2012
SF3B1 mutations in primary myelofibrosis: clinical, histopathology and genetic correlates among 155 patients Lasho, T. L.; Finke, C. M.; Hanson, C. A. Leukemia, Vol. 26, Issue 5 https://doi.org/10.1038/leu.2011.320	journal	November 2011
Cutting the cord from myelodysplastic syndromes: chronic myelomonocytic leukemia-specific biology and management strategies Padron, Eric; Steensma, David P. Current Opinion in Hematology, Vol. 22, Issue 2 https://doi.org/10.1097/moh.0000000000000112	journal	January 2015
250K Single Nucleotide Polymorphism Array Karyotyping Identifies Acquired Uniparental Disomy and Homozygous Mutations, Including Novel Missense Substitutions of c-Cbl, in Myeloid Malignancies Dunbar, A. J.; Gondek, L. P.; O'Keefe, C. L. Cancer Research, Vol. 68, Issue 24 https://doi.org/10.1158/0008-5472.can-08-2754	journal	December 2008
Bringing It All Together James, Jeanne; Robbins, Jeffrey Circulation Research, Vol. 117, Issue 12 https://doi.org/10.1161/circresaha.115.307874	journal	December 2015
Transcription intermediary factor 1γ is a tumor suppressor in mouse and human chronic myelomonocytic leukemia Aucagne, Romain; Droin, Nathalie; Paggetti, Jérôme Journal of Clinical Investigation, Vol. 121, Issue 6 https://doi.org/10.1172/jci45213	journal	June 2011
Predicting response to epigenetic therapy Treppendahl, Marianne B.; Kristensen, Lasse S.; Grønbæk, Kirsten Journal of Clinical Investigation, Vol. 124, Issue 1 https://doi.org/10.1172/jci69737	journal	January 2014
Clinical development of demethylating agents in hematology Navada, Shyamala C.; Steinmann, Juliane; Lübbert, Michael Journal of Clinical Investigation, Vol. 124, Issue 1 https://doi.org/10.1172/jci69739	journal	January 2014
Through the looking glass Alumkal, Joshi J. Blood, Vol. 114, Issue 16 https://doi.org/10.1182/blood-2009-08-238162	journal	October 2009
WHO classification of myeloid neoplasms and leukemia Wandt, Hannes; Haferlach, Torsten; Thiede, Christian Blood, Vol. 115, Issue 3 https://doi.org/10.1182/blood-2009-10-249664	journal	January 2010
Immune rage against MAGE unleashed Molldrem, Jeffrey J.; Alatrash, Gheath Blood, Vol. 116, Issue 11 https://doi.org/10.1182/blood-2010-06-292912	journal	September 2010
Mutations of ETNK1 in aCML and CMML Kosmider, Olivier Blood, Vol. 125, Issue 3 https://doi.org/10.1182/blood-2014-11-609057	journal	January 2015
Importance of Genetics in the Clinical Management of Chronic Myelomonocytic Leukemia Padron, Eric; Abdel-Wahab, Omar Journal of Clinical Oncology, Vol. 31, Issue 19 https://doi.org/10.1200/jco.2013.48.9120	journal	July 2013

Cited By (44)

Advances in chronic myelomonocytic leukemia and future prospects: Lessons learned from precision genomics Mangaonkar, Abhishek A.; Patnaik, Mrinal M. ADVANCES IN CELL AND GENE THERAPY, Vol. 2, Issue 2 https://doi.org/10.1002/acg2.48	journal	January 2019
Chronic myelomonocytic leukemia: 2018 update on diagnosis, risk stratification and management Patnaik, Mrinal M.; Tefferi, Ayalew American Journal of Hematology, Vol. 93, Issue 6 https://doi.org/10.1002/ajh.25104	journal	May 2018
Suboptimal response rates to hypomethylating agent therapy in chronic myelomonocytic leukemia; a single institutional study of 121 patients Coston, Tucker; Pophali, Prateek; Vallapureddy, Rangit American Journal of Hematology https://doi.org/10.1002/ajh.25488	journal	May 2019
Chronic Myelomonocytic leukemia: 2020 update on diagnosis, risk stratification and management Patnaik, Mrinal M.; Tefferi, Ayalew American Journal of Hematology, Vol. 95, Issue 1 https://doi.org/10.1002/ajh.25684	journal	October 2019
5-Azacytidine modulates CpG methylation levels of EZH2 and NOTCH1 in myelodysplastic syndromes Gawlitza, Anja L.; Speith, Johanna; Rinke, Jenny Journal of Cancer Research and Clinical Oncology, Vol. 145, Issue 11 https://doi.org/10.1007/s00432-019-03016-9	journal	September 2019
Cancer stem cells modulate patterns and processes of evolution in cancers Laplane, Lucie Biology & Philosophy, Vol. 33, Issue 3-4 https://doi.org/10.1007/s10539-018-9629-z	journal	May 2018
Number and type of TET2 mutations in chronic myelomonocytic leukemia and their clinical relevance Patnaik, M. M.; Zahid, M. F.; Lasho, T. L. Blood Cancer Journal, Vol. 6, Issue 9 https://doi.org/10.1038/bcj.2016.82	journal	September 2016
Dynamic changes in the clonal structure of MDS and AML in response to epigenetic therapy Uy, G. L.; Duncavage, E. J.; Chang, G. S. Leukemia, Vol. 31, Issue 4 https://doi.org/10.1038/leu.2016.282	journal	October 2016
Clonal evolution in myelodysplastic syndromes da Silva-Coelho, Pedro; Kroeze, Leonie I.; Yoshida, Kenichi Nature Communications, Vol. 8, Issue 1 https://doi.org/10.1038/ncomms15099	journal	April 2017
Dynamics of clonal evolution in myelodysplastic syndromes Makishima, Hideki; Yoshizato, Tetsuichi; Yoshida, Kenichi Nature Genetics, Vol. 49, Issue 2 https://doi.org/10.1038/ng.3742	journal	December 2016
Ongoing clonal evolution in chronic myelomonocytic leukemia on hypomethylating agents: a computational perspective Than, Hein; Qiao, Yi; Huang, Xiaomeng Leukemia, Vol. 32, Issue 9 https://doi.org/10.1038/s41375-018-0050-z	journal	March 2018
Blast-phase chronic myelomonocytic leukemia: more than just semantics Patnaik, Mrinal M.; Tefferi, Ayalew; Garcia-Manero, Guillermo Leukemia, Vol. 32, Issue 9 https://doi.org/10.1038/s41375-018-0228-4	journal	August 2018
Downregulating Notch counteracts KrasG12D-induced ERK activation and oxidative phosphorylation in myeloproliferative neoplasm Kong, Guangyao; You, Xiaona; Wen, Zhi Leukemia, Vol. 33, Issue 3 https://doi.org/10.1038/s41375-018-0248-0	journal	September 2018
Biology and prognostic impact of clonal plasmacytoid dendritic cells in chronic myelomonocytic leukemia Lucas, Nolwenn; Duchmann, Matthieu; Rameau, Philippe Leukemia, Vol. 33, Issue 10 https://doi.org/10.1038/s41375-019-0447-3	journal	March 2019
EZH2 mutations in chronic myelomonocytic leukemia cluster with ASXL1 mutations and their co-occurrence is prognostically detrimental Patnaik, Mrinal M.; Vallapureddy, Rangit; Lasho, Terra L. Blood Cancer Journal, Vol. 8, Issue 1 https://doi.org/10.1038/s41408-017-0045-4	journal	January 2018
Infrequent occurrence of TET1, TET3, and ASXL2 mutations in myelodysplastic/myeloproliferative neoplasms Lasho, Terra L.; Vallapureddy, Rangit; Finke, Christy M. Blood Cancer Journal, Vol. 8, Issue 3 https://doi.org/10.1038/s41408-018-0057-8	journal	March 2018
Multicenter validation of the flow measurement of classical monocyte fraction for chronic myelomonocytic leukemia diagnosis Tarfi, Sihem; Harrivel, Véronique; Dumezy, Florent Blood Cancer Journal, Vol. 8, Issue 11 https://doi.org/10.1038/s41408-018-0146-8	journal	November 2018
A miR-150/TET3 pathway regulates the generation of mouse and human non-classical monocyte subset Selimoglu-Buet, Dorothée; Rivière, Julie; Ghamlouch, Hussein Nature Communications, Vol. 9, Issue 1 https://doi.org/10.1038/s41467-018-07801-x	journal	December 2018
Understanding mutagenesis through delineation of mutational signatures in human cancer Petljak, Mia; Alexandrov, Ludmil B. Carcinogenesis, Vol. 37, Issue 6 https://doi.org/10.1093/carcin/bgw055	journal	May 2016
The evolving role of next generation sequencing in myelodysplastic syndromes Spaulding, Travis P.; Stockton, Shannon S.; Savona, Michael R. British Journal of Haematology, Vol. 188, Issue 2 https://doi.org/10.1111/bjh.16212	journal	August 2019
Rearrangement bursts generate canonical gene fusions in bone and soft tissue tumors Anderson, Nathaniel D.; de Borja, Richard; Young, Matthew D. Science, Vol. 361, Issue 6405 https://doi.org/10.1126/science.aam8419	journal	August 2018
How I treat chronic myelomonocytic leukemia Solary, Eric; Itzykson, Raphael Blood, Vol. 130, Issue 2 https://doi.org/10.1182/blood-2017-04-736421	journal	July 2017
MDS overlap disorders and diagnostic boundaries Tanaka, Tiffany N.; Bejar, Rafael Blood, Vol. 133, Issue 10 https://doi.org/10.1182/blood-2018-10-844670	journal	March 2019
DNA methylation identifies genetically and prognostically distinct subtypes of myelodysplastic syndromes Reilly, Brian; Tanaka, Tiffany N.; Diep, Dinh Blood Advances, Vol. 3, Issue 19 https://doi.org/10.1182/bloodadvances.2019000192	journal	October 2019
Comprehensive mutation profiling and mRNA expression analysis in atypical chronic myeloid leukemia in comparison with chronic myelomonocytic leukemia Faisal, Muhammad; Stark, Helge; Büsche, Guntram Cancer Medicine, Vol. 8, Issue 2 https://doi.org/10.1002/cam4.1946	journal	January 2019
CMML: Clinical and molecular aspects Itzykson, Raphael; Duchmann, Matthieu; Lucas, Nolwenn International Journal of Hematology, Vol. 105, Issue 6 https://doi.org/10.1007/s12185-017-2243-z	journal	April 2017
Turning the tide in myelodysplastic/myeloproliferative neoplasms Deininger, Michael W. N.; Tyner, Jeffrey W.; Solary, Eric Nature Reviews Cancer, Vol. 17, Issue 7 https://doi.org/10.1038/nrc.2017.40	journal	June 2017
A comparison of clinical and molecular characteristics of patients with systemic mastocytosis with chronic myelomonocytic leukemia to CMML alone Patnaik, Mrinal M.; Vallapureddy, Rangit; Lasho, Terra L. Leukemia, Vol. 32, Issue 8, p. 1850-1856 https://doi.org/10.1038/s41375-018-0121-1	journal	April 2018
Blast phase chronic myelomonocytic leukemia: Mayo-MDACC collaborative study of 171 cases Patnaik, Mrinal M.; Pierola, Ana A.; Vallapureddy, Rangit Leukemia, Vol. 32, Issue 11 https://doi.org/10.1038/s41375-018-0143-8	journal	April 2018
Heterogeneous expression of cytokines accounts for clinical diversity and refines prognostication in CMML Niyongere, Sandrine; Lucas, Nolwenn; Zhou, Jun-Min Leukemia, Vol. 33, Issue 1 https://doi.org/10.1038/s41375-018-0203-0	journal	July 2018
Clinical, molecular, and prognostic correlates of number, type, and functional localization of TET2 mutations in chronic myelomonocytic leukemia (CMML)—a study of 1084 patients Coltro, Giacomo; Mangaonkar, Abhishek A.; Lasho, Terra L. Leukemia, Vol. 34, Issue 5 https://doi.org/10.1038/s41375-019-0690-7	journal	December 2019
Biallelic inactivation of the retinoblastoma gene results in transformation of chronic myelomonocytic leukemia to a blastic plasmacytoid dendritic cell neoplasm: shared clonal origins of two aggressive neoplasms Patnaik, Mrinal M.; Lasho, Terra; Howard, Matthew Blood Cancer Journal, Vol. 8, Issue 9 https://doi.org/10.1038/s41408-018-0120-5	journal	August 2018
Dynamic gene regulation by nuclear colony-stimulating factor 1 receptor in human monocytes and macrophages Bencheikh, Laura; Diop, M’Boyba Khadija; Rivière, Julie Nature Communications, Vol. 10, Issue 1 https://doi.org/10.1038/s41467-019-09970-9	journal	April 2019
Incidence and survival outcomes of chronic myelomonocytic leukemia in the United States Guru Murthy, Guru Subramanian; Dhakal, Ishwori; Mehta, Paulette Leukemia & Lymphoma, Vol. 58, Issue 7 https://doi.org/10.1080/10428194.2016.1258700	journal	November 2016
Mutational landscape and response are conserved in peripheral blood of AML and MDS patients during decitabine therapy Duncavage, Eric J.; Uy, Geoffrey L.; Petti, Allegra A. Blood, Vol. 129, Issue 10 https://doi.org/10.1182/blood-2016-10-745273	journal	March 2017
How I treat MDS after hypomethylating agent failure Santini, Valeria Blood, Vol. 133, Issue 6 https://doi.org/10.1182/blood-2018-03-785915	journal	February 2019
Direct modulation of the bone marrow mesenchymal stromal cell compartment by azacitidine enhances healthy hematopoiesis Wenk, Catharina; Garz, Anne-Kathrin; Grath, Sonja Blood Advances, Vol. 2, Issue 23 https://doi.org/10.1182/bloodadvances.2018022053	journal	December 2018
A clinical-molecular update on azanucleoside-based therapy for the treatment of hematologic cancers Diesch, Jeannine; Zwick, Anabel; Garz, Anne-Kathrin Clinical Epigenetics, Vol. 8, Issue 1 https://doi.org/10.1186/s13148-016-0237-y	journal	June 2016
The repertoire of mutational signatures in human cancer Alexandrov, Ludmil B.; Kim, Jaegil; Haradhvala, Nicholas J. Nature, Vol. 578, Issue 7793 https://doi.org/10.1038/s41586-020-1943-3	journal	February 2020
Impact of baseline cytogenetic findings and cytogenetic response on outcome of high-risk myelodysplastic syndromes and low blast count AML treated with azacitidine Sébert, Marie; Komrokji, Rami S.; Sekeres, Mikkael A. Leukemia Research, Vol. 63 https://doi.org/10.1016/j.leukres.2017.10.013	journal	December 2017
Seave: a comprehensive web platform for storing and interrogating human genomic variation Gayevskiy, Velimir; Roscioli, Tony; Dinger, Marcel E. Bioinformatics, Vol. 35, Issue 1 https://doi.org/10.1093/bioinformatics/bty540	journal	July 2018
Dark selection for JAK/STAT-inhibitor resistance in chronic myelomonocytic leukemia Kaznatcheev, Artem; Grimes, David Robert; Velde, Robert Vander https://doi.org/10.1101/211151	preprint	October 2017
CBL family E3 ubiquitin ligases control JAK2 ubiquitination and stability in hematopoietic stem cells and myeloid malignancies Lv, Kaosheng; Jiang, Jing; Donaghy, Ryan Genes & Development, Vol. 31, Issue 10 https://doi.org/10.1101/gad.297135.117	journal	May 2017
Genomic Biomarkers to Predict Resistance to Hypomethylating Agents in Patients With Myelodysplastic Syndromes Using Artificial Intelligence Nazha, Aziz; Sekeres, Mikkael A.; Bejar, Rafael JCO Precision Oncology, Issue 3 https://doi.org/10.1200/po.19.00119	journal	December 2019

Similar Records

Selective inactivation of hypomethylating agents by SAMHD1 provides a rationale for therapeutic stratification in AML

Journal Article · Fri Aug 02 00:00:00 EDT 2019 · Nature Communications · OSTI ID:1246362

Oellerich, Thomas; Schneider, Constanze; Thomas, Dominique; +21 more

Amyloid protein-mediated differential DNA methylation status regulates gene expression in Alzheimer's disease model cell line

Journal Article · Fri Nov 04 00:00:00 EDT 2011 · Biochemical and Biophysical Research Communications · OSTI ID:1246362

Sung, Hye Youn; Choi, Eun Nam; Ahn Jo, Sangmee; +2 more

Inhibition of DNA methylation in P. soloecismus alters algae productivity

Journal Article · Thu Oct 15 00:00:00 EDT 2020 · Frontiers in Genetics · OSTI ID:1246362

Steadman, Christina Rene; Banerjee, Shounak; Kunde, Yuliya A.; +3 more

Related Subjects

59 BASIC BIOLOGICAL SCIENCES
biological sciences
cancer
genetics

Title: Mutation allele burden remains unchanged in chronic myelomonocytic leukaemia responding to hypomethylating agents

Citation Formats

References (89)

Cited By (44)

Similar Records

Related Subjects